XASXMCP
Market cap28mUSD
Jan 10, Last price
0.33AUD
1D
0.00%
1Q
-18.75%
Jan 2017
-68.45%
Name
McPherson's Ltd
Chart & Performance
Profile
McPherson's Limited provides health, wellness, and beauty products in Australia, New Zealand, Asia, and internationally. It offers beauty care, hair care, skin care, and personal care items, including facial wipes, cotton pads, and foot comfort products; and vitamins and supplements, as well as various kitchen essentials, such as baking papers, cling wraps, and aluminium foils. The company sells its products primarily under the owned brands, including Dr. LeWinn's, A'kin, Manicare, Lady Jayne, Swisspers, Multix, Fusion Health, Oriental Botanicals, Moosehead, and Maseur. The company was founded in 1860 and is based in Kingsgrove, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 144,625 -31.22% | 210,261 -1.75% | 214,003 6.74% | |||||||
Cost of revenue | 130,897 | 226,136 | 238,787 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 13,728 | (15,875) | (24,784) | |||||||
NOPBT Margin | 9.49% | |||||||||
Operating Taxes | (1,350) | 389 | 103 | |||||||
Tax Rate | ||||||||||
NOPAT | 15,078 | (16,264) | (24,887) | |||||||
Net income | (15,991) 215.97% | (5,061) -1,619.82% | 333 -106.20% | |||||||
Dividends | (4,318) | (5,758) | (5,789) | |||||||
Dividend yield | 7.32% | 10.13% | 6.17% | |||||||
Proceeds from repurchase of equity | (2) | (6) | ||||||||
BB yield | 0.00% | 0.01% | ||||||||
Debt | ||||||||||
Debt current | 14,288 | 4,663 | 18,458 | |||||||
Long-term debt | 14,528 | 28,980 | 21,844 | |||||||
Deferred revenue | 8,194 | (1) | ||||||||
Other long-term liabilities | 1,435 | 2,255 | 1,409 | |||||||
Net debt | 4,047 | 60,341 | 60,804 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 12,343 | 6,548 | 18,575 | |||||||
CAPEX | (1,139) | (1,849) | (2,255) | |||||||
Cash from investing activities | 16,294 | (1,849) | (2,255) | |||||||
Cash from financing activities | (10,901) | (10,910) | (10,594) | |||||||
FCF | 19,917 | (6,006) | (26,348) | |||||||
Balance | ||||||||||
Cash | 24,769 | 7,031 | 13,139 | |||||||
Long term investments | (33,729) | (33,641) | ||||||||
Excess cash | 17,538 | |||||||||
Stockholders' equity | 89,637 | 109,452 | 120,806 | |||||||
Invested Capital | 93,386 | 122,469 | 151,529 | |||||||
ROIC | 13.97% | |||||||||
ROCE | 11.99% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 143,949 | 143,869 | 143,178 | |||||||
Price | 0.41 3.80% | 0.40 -39.69% | 0.66 -40.45% | |||||||
Market cap | 59,019 3.86% | 56,828 -39.40% | 93,782 -29.64% | |||||||
EV | 63,066 | 117,169 | 154,586 | |||||||
EBITDA | 19,638 | (9,890) | (19,110) | |||||||
EV/EBITDA | 3.21 | |||||||||
Interest | 1,905 | 1,786 | 1,175 | |||||||
Interest/NOPBT | 13.88% |